John Gourary leads Covington's Royalty Monetization practice. He has over 30 years of experience in all kinds of bank finance transactions (including syndicated loan transactions, acquisition finance, structured finance, and innovative financings of unusual asset classes). Mr. Gourary has handled transactions in these areas for, among others, Aristocrat Leisure Limited, Athyrium Capital, Canada Pension Plan Investment Board, Dana-Farber Cancer Institute, Duke University, Emory University, LIN Media, Medical Research Council Technology, Northwestern University, OrbiMed, Pfizer, SandRidge Energy, The Kennedy Trust for Rheumatology Research, University of Colorado, University of Pennsylvania, University of Rochester, and Zurich Financial Services.
Mr. Gourary specializes in royalty monetizations (the acquisition and financing (or sale) of pharmaceutical royalty streams). He has been involved in the royalty monetization market from its early stages and has advised on royalty monetization transactions with an aggregate value in excess of $6 billion. Mr. Gourary advises all the principal participants in these transactions, including major universities and non-profit institutions, financial investors, individual inventors, and life sciences companies.